OpenAI researcher Miles Wang plans $2B AI drug discovery startup
Miles Wang, a researcher at OpenAI, is in talks to launch an AI-powered drug discovery startup valued at $2 billion. Lightspeed venture capital is in discussions to lead the funding round, according to sources familiar with the matter.
Comments
No comments yet
Comments
No comments yet โ be the first to weigh in ๐
No comments yet. Be the first!